RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 120 filers reported holding RA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 4.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,228,000 | -34.6% | 25,580 | -36.0% | 0.00% | 0.0% |
| Q4 2019 | $1,877,000 | -49.7% | 40,000 | -74.6% | 0.00% | -60.0% |
| Q3 2019 | $3,729,000 | -70.3% | 157,655 | -62.2% | 0.01% | -68.8% |
| Q2 2019 | $12,535,000 | +3.9% | 416,870 | -22.6% | 0.02% | 0.0% |
| Q1 2019 | $12,070,000 | +168.2% | 538,846 | +117.9% | 0.02% | +166.7% |
| Q4 2018 | $4,500,000 | +135.0% | 247,242 | +133.6% | 0.01% | +200.0% |
| Q3 2018 | $1,915,000 | +790.7% | 105,847 | +389.6% | 0.00% | – |
| Q2 2018 | $215,000 | -48.4% | 21,620 | -24.3% | 0.00% | -100.0% |
| Q3 2017 | $417,000 | +2.2% | 28,563 | +31.3% | 0.00% | 0.0% |
| Q2 2017 | $408,000 | -49.4% | 21,756 | -42.5% | 0.00% | 0.0% |
| Q1 2017 | $806,000 | +28.1% | 37,844 | -8.6% | 0.00% | 0.0% |
| Q4 2016 | $629,000 | – | 41,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |